Revolution Medicines' drug for pancreatic cancer succeeded in a highly anticipated Phase 3 trial, the company said.
Read full articleRevolution Medicines says its potential breakthrough pancreatic cancer drug succeeds in late-stage trial
Written on 04/13/2026

